Bredin Investment’s Pfizer PFE Stock Holding History

Bredin Investment’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$323K	Hold	8,690	–	–	0.26%	70
2019 Q3	$296K	Hold	8,690	–	–	0.26%	71
2019 Q2	$350K	Hold	8,690	–	–	0.31%	66
2019 Q1	$350K	Hold	8,690	–	–	0.31%	63
2018 Q4	$360K	Hold	8,690	–	–	0.34%	62
2018 Q3	$363K	Hold	8,690	–	–	0.3%	66
2018 Q2	$299K	Hold	8,690	–	–	0.23%	71
2018 Q1	$293K	Hold	8,690	–	–	0.25%	70
2017 Q4	$300K	Buy	+8,690	New	+$296K	0.24%	72

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bredin Investment's PFE Position: Q4 2019 in Review

Bredin Investment held its Pfizer (PFE) position steady in Q4 2019 at 8,690 shares worth $323K. The position accounts for 0.26% of the portfolio, ranked #70.

Bredin Investment first reported a position in PFE in Q4 2017 and has held it in 9 quarters since. The position peaked at $363K in Q3 2018. 2,525 funds tracked by Wall St. Rank hold PFE as of Q4 2019.

Bredin Investment held 8,690 shares of Pfizer worth $323K as of Q4 2019.
Bredin Investment left its Pfizer share count unchanged in Q4 2019.
Pfizer made up 0.26% of Bredin Investment's portfolio in Q4 2019, its #70 holding.
Bredin Investment first reported a position in Pfizer in Q4 2017 and has held it in 9 quarters since.
Bredin Investment's Pfizer position peaked at $363K in Q3 2018.
2,525 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.

Based on Bredin Investment's 13F filing for Q4 2019, filed 6 Feb 2020.